Argen X NV revenue breakdown overview

Argen X NV revenue for the last year amounted to 1.29 B USD, the most of which — 1.25 B USD — came from its highest performing source at the moment, Antibody-based Medicines, the year earlier bringing 418.28 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Argen X NV 1.10 B USD, and the year before that — 384.59 M USD.